Clinical Trial Update: Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer [Phase 2]

View source ↗

Summary

A Phase II clinical trial is investigating intermittent high-dose icotinib in combination with docetaxel for non-small cell lung cancer; trial status is not pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• icotinib (icotinib)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN